Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Lung Neoplasms 3 Anxiety Disorders 3 Solitary Pulmonary Nodule 2 Paresthesia 2 Multiple Pulmonary Nodules 2 Hypesthesia 2 Dyspnea 2 Depression 2 Brain Neoplasms 2 Surgical Wound Infection 1 Skin Neoplasms 1 Radiation Injuries 1 Pulmonary Atelectasis 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Prostatic Diseases 1 Postoperative Complications 1 Pain 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia 1 Inflammatory Bowel Diseases 1 Hypoxia 1 Hematologic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 6 TH 302 4 Radiotherapy 4 pimonidazole 3 fluoroazomycin arabinoside 3 Propofol 3 Injections 3 Positron Emission Tomography Computed Tomography 2 Blood Specimen Collection 2 Bacterial Load 2 pomalidomide 1 pembrolizumab 1 inositol trispyrophosphate 1 gadobutrol 1 fluoromisonidazole 1 fludarabine 1 Tirapazamine 1 Temozolomide 1 Sodium Chloride 1 Sevoflurane 1 Saline Solution 1 Pancreaticoduodenectomy 1 Paclitaxel 1 Oxygen 1 Nitroglycerin 1 Nimorazole 1 NVP-BKM120 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Ketamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hypoxia × Oxygen × Clear all

NCT04566419 2022-09-16

SAMURAI

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Completed

Hypoxia, Pulmonary Atelectasis, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡